• Novel therapeutics in thoracic cancers including early phase trials
  • Targeted therapy trials, genomics in thoracic cancers
  • Immunotherapy trials in thoracic cancers¬†
  • Novel diagnostics including practical applications of liquid biopsy
  • Outcomes research¬†

 

For a list of Dr. Leighl's publications, please visit PubMed or Scopus.


Professor, Department of Medicine, University of Toronto
Professor (status), Institute of Health Policy, Management and Evaluation, University of Toronto
Past President and Honorary Lifetime Member, Lung Cancer Canada
Past Chair, Committee on Economic Analysis, Canadian Clinical Trials Group